E-GLOBE SPA (EGB.MI) Fundamental Analysis & Valuation

BIT:EGB • IT0005557514

Current stock price

0.5 EUR
-0.14 (-21.87%)
Last:

This EGB.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EGB.MI Profitability Analysis

1.1 Basic Checks

  • In the past year EGB has reported negative net income.
EGB.MI Yearly Net Income VS EBIT VS OCF VS FCFEGB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

  • With a Return On Assets value of -9.76%, EGB is not doing good in the industry: 77.59% of the companies in the same industry are doing better.
  • EGB has a Return On Equity of -22.84%. This is in the lower half of the industry: EGB underperforms 74.14% of its industry peers.
Industry RankSector Rank
ROA -9.76%
ROE -22.84%
ROIC N/A
ROA(3y)3.95%
ROA(5y)N/A
ROE(3y)12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EGB.MI Yearly ROA, ROE, ROICEGB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EGB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EGB.MI Yearly Profit, Operating, Gross MarginsEGB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

4

2. EGB.MI Health Analysis

2.1 Basic Checks

  • EGB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EGB has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, EGB has a worse debt to assets ratio.
EGB.MI Yearly Shares OutstandingEGB.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
EGB.MI Yearly Total Debt VS Total AssetsEGB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • EGB has an Altman-Z score of 1.72. This is a bad value and indicates that EGB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.72, EGB perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
  • A Debt/Equity ratio of 0.20 indicates that EGB is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.20, EGB belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC6.42%
EGB.MI Yearly LT Debt VS Equity VS FCFEGB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • EGB has a Current Ratio of 1.69. This is a normal value and indicates that EGB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.69, EGB is doing good in the industry, outperforming 79.31% of the companies in the same industry.
  • EGB has a Quick Ratio of 1.16. This is a normal value and indicates that EGB is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.16, EGB belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.16
EGB.MI Yearly Current Assets VS Current LiabilitesEGB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

2

3. EGB.MI Growth Analysis

3.1 Past

  • EGB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -244.06%.
  • Looking at the last year, EGB shows a decrease in Revenue. The Revenue has decreased by -9.53% in the last year.
  • Measured over the past years, EGB shows a very strong growth in Revenue. The Revenue has been growing by 20.33% on average per year.
EPS 1Y (TTM)-244.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-317.99%
Revenue 1Y (TTM)-9.53%
Revenue growth 3Y20.33%
Revenue growth 5YN/A
Sales Q2Q%-1.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EGB.MI Yearly Revenue VS EstimatesEGB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M 25M

0

4. EGB.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EGB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EGB.MI Price Earnings VS Forward Price EarningsEGB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EGB.MI Per share dataEGB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. EGB.MI Dividend Analysis

5.1 Amount

  • No dividends for EGB!.
Industry RankSector Rank
Dividend Yield 0%

EGB.MI Fundamentals: All Metrics, Ratios and Statistics

E-GLOBE SPA

BIT:EGB (4/7/2026, 7:00:00 PM)

0.5

-0.14 (-21.87%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.76M
Revenue(TTM)26.78M
Net Income(TTM)-2.12M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.98
BVpS0.69
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.76%
ROE -22.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.95%
ROA(5y)N/A
ROE(3y)12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.16
Altman-Z 1.72
F-ScoreN/A
WACC6.42%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-317.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.53%
Revenue growth 3Y20.33%
Revenue growth 5YN/A
Sales Q2Q%-1.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-158.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

E-GLOBE SPA / EGB.MI Fundamental Analysis FAQ

What is the fundamental rating for EGB stock?

ChartMill assigns a fundamental rating of 2 / 10 to EGB.MI.


Can you provide the valuation status for E-GLOBE SPA?

ChartMill assigns a valuation rating of 0 / 10 to E-GLOBE SPA (EGB.MI). This can be considered as Overvalued.


What is the profitability of EGB stock?

E-GLOBE SPA (EGB.MI) has a profitability rating of 0 / 10.


How financially healthy is E-GLOBE SPA?

The financial health rating of E-GLOBE SPA (EGB.MI) is 4 / 10.